VBIO ▼ -0.5% - Valion Bio, Inc.
$VBIO - Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
09-OCT-2026 07:47 AM ET
Share this post
More filings for $VBIO
VBIO ▼ -0.5% - Valion Bio, Inc.Oct 9, 2026VBIO ▼ -6.3% - Valion Bio, Inc.Oct 5, 2026VBIO ▲ +20.1% - Valion Bio, Inc.Sep 30, 2026VBIO ▲ +8.4% - Valion Bio, Inc.Sep 23, 2026VBIO ▼ -1.7% - Valion Bio, Inc.Sep 22, 2026VBIO ▼ -5.6% - Valion Bio, Inc.Sep 1, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment